CIK 0001615219
- Non-accelerated filer
- Smaller reporting company
Decoy Therapeutics Inc.
Sign in to watch- Ticker
- DCOY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 465087339
- Phone
- +1 346-772-0346
- Business address
- 2450 HOLCOMBE BLVD, SUITE J-608, HOUSTON, TX, 77021
- Former names
- Salarius Pharmaceuticals, Inc., Flex Pharma, Inc.
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- S-3 Offering Registration Statement
- 10-Q Report Quarterly Report
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
- S-1 Offering Registration Statement
- 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure
- 8-K Event Shareholder vote results
- 4 Grant or award Director acquired 2,000 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 33,455 shares (grant or award)
- 4 Grant or award Chief Business Officer acquired 3,900 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 9,682 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 4,216 shares (grant or award)
- 4 Grant or award Director acquired 3,000 shares (grant or award)
- 4 Grant or award Director acquired 2,000 shares (grant or award)
- 4 Grant or award Director acquired 2,000 shares (grant or award)
- 4 Grant or award Director acquired 3,000 shares (grant or award)
- 4 Grant or award Director acquired 2,000 shares (grant or award)
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
Page 1 of 38 · 746 filings